Nevro registers $100m IPO
Nevro Corp. said it plans to raise more than $100 million in an initial public offering of stock for its implantable spinal cord stimulation system to treat chronic pain.
Proxy war rages on at Echo Therapeutics
Echo Therapeutics‘ (NSDQ:ECTE) suspension of operations hasn’t stopped a pair of recently appointed renegade board members from using their perch to agitate for change.